The lungs have no ability to make up for the loss of that channel.
Across four unrelated families on three continents, five children have suffered from a lung disease so rare and so poorly understood that it had no name — until now. Researchers tracing a single undiagnosed patient through a federally funded medical mystery program have identified mutations in the TMEM63B gene as the hidden cause, revealing that when both copies of this ion channel gene fail entirely, the lungs — unlike the brain — have no way to compensate. The discovery is a reminder that the rarest suffering often requires the widest collaboration to illuminate, and that a diagnosis, however late in coming, is itself a form of relief.
- Five children born into respiratory crisis had no diagnosis, no framework, and no roadmap — only lungs that could not do their most basic work.
- The genetic culprit, TMEM63B, had been studied before, but only in its overactive form; the possibility that total loss of the gene could devastate lungs while sparing the brain was entirely unknown.
- A single case posted online by researchers in Texas acted as a beacon, drawing three more families from Asia and Europe who carried the same broken genetic signature.
- The lung's vulnerability comes down to a cruel biological asymmetry: the brain can recruit backup ion channels when TMEM63B goes silent, but lung tissue has no such redundancy.
- With the cause now named and published in a major genetics journal, clinicians worldwide have a new target for screening, and future children may be identified and treated before the disease reaches its most dangerous stages.
A team of geneticists spanning Texas, Asia, and Europe has identified the genetic cause of a rare and severe childhood lung disease — mutations in a gene called TMEM63B that leave lung cells without a critical ion channel they cannot replace.
The discovery began with a single child enrolled in the Undiagnosed Diseases Network, a federally funded program built to solve medical mysteries. When researchers at Texas Children's Hospital and Baylor College of Medicine shared that child's case online, four more patients from three other families emerged with the same genetic signature: respiratory distress beginning in infancy, damaged lung tissue, and developmental delays — but no epilepsy.
What makes the finding especially illuminating is the contrast it draws between two opposite kinds of genetic failure. Scientists already knew that inheriting one overactive copy of TMEM63B causes neurological problems — seizures, developmental delays, epilepsy. But no one had studied what happens when both copies fail entirely. The answer, it turns out, depends on which organ you ask. The brain adapts, recruiting other ion channels to fill the gap. The lungs do not. There is no backup system, no redundancy — and so the five children in this study developed life-threatening lung disease while their brains remained largely spared.
The condition falls within childhood interstitial lung disease, a family of disorders that damage the lung tissue responsible for gas exchange. Early diagnosis and aggressive management are essential to survival. Dr. Keren Machol, a clinical geneticist at Texas Children's, noted that identifying TMEM63B as a cause changes how doctors approach both diagnosis and care — giving answers to families who had none, and giving clinicians a new target to search for in future patients.
Lead author Dr. Sock Hoai Chan of KK Women's and Children's Hospital and Duke-NUS Medical School in Singapore credited the discovery to global partnership. Without the infrastructure to connect patients across borders and the willingness of researchers to share data, this condition might have remained invisible for years. Instead, five children now have a diagnosis — and the medical world has a new disease to recognize.
A team of geneticists working across Texas, Asia, and Europe has identified the culprit behind a rare and severe form of childhood lung disease: mutations in a gene called TMEM63B that rob the lungs of a critical ion channel they cannot replace.
The discovery emerged from a single patient who enrolled in the Undiagnosed Diseases Network, a federally funded program designed to solve medical mysteries. Researchers at Texas Children's Hospital and Baylor College of Medicine posted details of this child's case online, and within the research community, the signal was unmistakable. Four more patients from three other families came forward with the same genetic signature and the same constellation of symptoms: respiratory distress appearing in infancy, abnormal lung tissue, and developmental delays. None had epilepsy. The findings now appear in the American Journal of Human Genetics.
What makes this discovery particularly striking is how it illuminates the difference between two opposite kinds of genetic malfunction. Scientists had previously documented that when people inherit a single faulty copy of TMEM63B—a gain-of-function mutation that leaves the gene overactive—they develop neurological problems: developmental delays, seizures, epilepsy. The brain, it turns out, is exquisitely sensitive to this kind of excess. But no one had systematically studied what happens when a person inherits two broken copies, one from each parent, both of which fail to work at all.
TMEM63B encodes an ion channel, a protein that acts like a gated doorway in the cells lining the lungs and nervous system. When the channel malfunctions in the gain-of-function way, it gets stuck open when it should close. The brain suffers. But when both copies are lost entirely, the channel vanishes. Here is where the story takes an unexpected turn: the brain compensates. Other ion channels step in and do the work. The nervous system adapts. The lungs do not. In lung tissue, there is no backup system, no redundancy, no way to make up for the missing channel. This is why the five affected children in this study developed severe, life-threatening lung disease while their brains remained largely unaffected.
The condition belongs to a family of disorders called childhood interstitial lung disease, diseases that damage the delicate tissue inside the lungs responsible for gas exchange. Many such diseases stem from defects in surfactant, the substance that allows lungs to inflate and deflate with each breath. Without it, or with it malformed, breathing becomes a crisis. Early diagnosis and aggressive management are essential. The children in this study faced respiratory distress from birth or early infancy, their lungs unable to do the work they were designed for.
Dr. Keren Machol, a clinical geneticist at Texas Children's, emphasized the practical weight of this finding. Identifying TMEM63B variants as a novel cause of this condition changes how doctors approach diagnosis and treatment. Families who have lost children to undiagnosed lung disease, or who have watched their children struggle without knowing why, now have answers. Clinicians and diagnostic laboratories have a new target to search for. Future children born with similar mutations can be identified sooner, managed more aggressively, and given the best chance at survival.
The research itself is a product of what Dr. Sock Hoai Chan, the study's lead author, calls the power of global partnership. Chan works at KK Women's and Children's Hospital and Duke-NUS Medical School in Singapore. The team included collaborators across continents. One patient in Texas. Others in Asia and Europe. Without the infrastructure to match patients across borders, without the willingness of researchers to share findings and pool data, this rare condition might have remained invisible for years. Instead, five children and their families now have a diagnosis, and the medical world has a new disease to watch for.
Citações Notáveis
Identifying variants in TMEM63B as a novel cause of this condition can significantly impact management of patients with this rare disorder.— Dr. Keren Machol, clinical geneticist at Texas Children's
The brain has other channels that can pick up the slack. But in the lung, there is no ability to make up for the loss of that channel.— Dr. Jill Rosenfeld, Baylor College of Medicine
A Conversa do Hearth Outra perspectiva sobre a história
Why does the brain tolerate the loss of this channel when the lungs cannot?
Because the brain has built-in redundancy. Other ion channels can compensate. The lungs evolved differently—they depend on this specific channel and have no backup.
So the same gene mutation causes completely different diseases depending on whether it's overactive or inactive?
Exactly. Overactive breaks the brain. Inactive breaks the lungs. It's a reminder that genes don't have a single job—context matters enormously.
How did researchers find these five patients if the condition is so rare?
One child was enrolled in the Undiagnosed Diseases Network. When they posted the case online, other families recognized themselves. That's how rare disease discovery often works now—you need visibility and connection.
What happens to these children without a diagnosis?
They're treated for symptoms—respiratory support, intensive care—but doctors don't know what they're fighting. With a diagnosis, you can target the root cause and manage it more effectively.
Is there a treatment yet?
Not yet. But naming the disease is the first step. Now researchers know what to study. Families know what to watch for in future pregnancies. That's how rare disease medicine advances.